SCHEMBL6685416

SCHEMBL6685416

COC(=O)C1=CNCN=C1

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 1/20 0.35
MAPK1 P28482 2/20 0.34
TSHR P16473 2/20 0.33
CHRM3 P20309 1/20 0.33
KDM4E B2RXH2 2/20 0.32
ALDH1A1 P00352 2/20 0.32
CA12 O43570 3/20 0.31
CA1 P00915 3/20 0.31
CA2 P00918 3/20 0.31
CA7 P43166 3/20 0.31
CA9 Q16790 3/20 0.31
CA14 Q9ULX7 3/20 0.31
TDP1 Q9NUW8 1/20 0.31
STAT3 P40763 1/20 0.31
HIF1A Q16665 1/20 0.31
CYP1A2 P05177 1/20 0.31
ATM Q13315 1/20 0.31
KDM4C Q9H3R0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2428098 0.78
SCHEMBL14472183 0.73 CHRM3 (0.33) NPSR1MAPK1TSHRCHRM3KDM4E
SCHEMBL23496634 0.68 CHRM3 (0.36) NPSR1MAPK1TSHRCHRM3CA12
SCHEMBL30354331 0.68 NPSR1 (0.34) NPSR1MAPK1TSHRKDM4EALDH1A1
Hydrochloric Acid SCHEMBL22634307 0.67 KDM4E (0.35) NPSR1MAPK1TSHRCHRM3KDM4E
SCHEMBL19067575 0.66 NOTUM (0.35) MAPK1TSHRCHRM3KDM4EALDH1A1
SCHEMBL14816564 0.63 TSHR (0.34) NPSR1MAPK1TSHRKDM4EALDH1A1
SCHEMBL12502801 0.62 SLC6A3 (0.42) TSHRCHRM3ALDH1A1
SCHEMBL20599624 0.61 NPSR1 (0.35) NPSR1MAPK1TSHRCHRM3KDM4E
SCHEMBL6021710 0.61 KDM4E (0.33) NPSR1MAPK1TSHRCHRM3KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109640980-A Combination and method comprising shell assembly inhibitor 诺维拉治疗公司 2019-04-16 CN disclosed
WO-2004064774-A2 DNA ENCODING A HUMAN MELANIN CONCENTRATING HORMONE RECEPTOR (MCH1) AND USES THEREOF SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2004-08-05 WO disclosed